Australia’s new research reactor: commissioning, operation,...

71
Australia Australia s new research reactor: commissioning, operation, s new research reactor: commissioning, operation, opportunities & challenges in engineering, physics & biology opportunities & challenges in engineering, physics & biology OPAL OPAL

Transcript of Australia’s new research reactor: commissioning, operation,...

Page 1: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

AustraliaAustralia’’s new research reactor: commissioning, operation, s new research reactor: commissioning, operation, opportunities & challenges in engineering, physics & biologyopportunities & challenges in engineering, physics & biology

OPALOPAL

Page 2: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Sydney

ANSTO Site

Page 3: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Introducing ANSTO

• Centre of Australian nuclear expertise

• Home of Australia’s only nuclear reactors

• Australian government science and technology organisation

• Around 900 employees

• Addressing issues such as health care, environment protection, assistance to industry and regional interactions

Page 4: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Our visionTo be recognised as an international centre

of excellence in nuclear science and technology for the benefit of Australia

Page 5: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL Research Reactor and applications

A centre of excellence for the benefit of AustraliaA centre of excellence for the benefit of Australia

Page 6: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Research reactor operation HIFAR operating since 1958

National facilities Centre of Excellence

Neutron beams for science

Radio-isotopes for medicine and industry

Commercial & research irradiations

Page 7: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Enhanced capabilities at OPAL • Neutron Beams: 2 to 4 orders of magnitude at detectors

• Radioisotopes: Up to 10 times higher capacity

• Silicon production: Capacity doubled

• Cold neutron source: Large liquid deuterium source

• Passive safety features: Natural convection cooling

• Digital control and protection systems:

• Pool reactor: Easier utilisation

• Working environment: Many beam users outside containment

• Spent fuel storage: 10 year storage in facility

Page 8: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL Reactor• Multi-purpose facility – neutron beams,

radiopharmaceuticals, irradiation of materials• 20 MW thermal power• Compact core (~300 kW/L)• Plate type Low Enriched Uranium fuel• D2O reflector• Upward coolant flow (light water)• 2 independent & diverse shutdown systems

Page 9: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Construction Time Lapse

Page 10: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Design

Page 11: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Coolant Channels between Fuel Plates

Central Control Rod

Hf Control Rods

Fuel Assemblies

Fuel Plates

Reactor CoreReactor Core

Page 12: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Reflector facilities

Pneumatic transfer system tubes

PCS suction line

Si rigsCNS

Core Bulk irradiation facilities

Page 13: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Rigs and cans

TARGETS

NOZZLE

Silicon Ingot

Bottom Silicon Dummy

Silicon Ingot

Silicon Ingot

Lifting Lug Top Dummy

Page 14: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Beam facilitiesAssembly #1

Thermal Beam

Assembly #2Cold Beam

Assembly #4Thermal Beam

Assembly #5Hot Beam

Assembly #3Cold Beam

(Future)

Page 15: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

CNS

MODERATOR CELL JACKET

DISPLACER

MODERATOR CELL

D2 INLET D2 OUTLET

He INLET

He OUTLET

Page 16: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Beams for neutron scattering science

Page 17: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL / Neutron Guide Hall

Page 18: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Reactor face, guide bunker & neutron guides

Mirrotron engineers installing out-of-pile neutron guides

guide bunker TG4CG4

TG1 TG3

Thermal neutron guides run ~ 40m in bunker

150 x 50 mm300 x 50 mm

neutron guide cross-sectionBeams vary from 50 -100 mm wide and from 150 - 300 mm high at exit window

Page 19: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Opal neutron beam instruments & mascots

Neutron diffraction

Large scale structures

Inelastic neutron scattering

Platypus (Reflect)Quokka (SANS)

Wombat (HIPD)

Kowari (Resid. Stress)

Echidna (HRPD)

Koala (QLD)

Taipan (Triple Axis)

Sika (Cold-Triple Axis) Pelican (TOF-PAS)

Scheduled for completion in 2009

Page 20: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Acceptance testing – fluxes & spectra

0

10000

20000

30000

40000

50000

60000

0 1 2 3 4 5

wavelength (A)ne

utro

n co

unts

0

2000

4000

6000

8000

10000

12000

14000

16000

18000

20000

TG4 15 Oct, 300kW

TG3 235U 17 Dec (no coll)

TG3 235U 16 Dec (coll)TG4 spectrum

Peak in collimated spectrum is at λ = 1.4 ÅPeak in un-collimated spectrum shifted to longer wavelength Spectrum is satisfactory

TG3 Au foil measurementΦ = 8.4 x 109 n/cm2/s (2nd break after RF)

Estimate ΦRF ≤ 3.4 x 1010 n/cm2/s

TG1 Au foil measurementΦ = 1.24 x 1010 n/cm2/s (2nd break after RF)

Estimate ΦRF ≤ 5.0 x 1010 n/cm2/s

Φ = 3.3 x 109 n/cm2/s ( Wombat)

c.f. predicted value of 2.4 x 109

Page 21: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL: thermal neutron distributions

Kowari1

2

3

4

5

6

7A B C

Wombat

2 % contoursvariation:

10% (h) x 2% (v)

Φ = 2.9 x 109 n/cm2/s Φ(10-100 meV) = 2.1 x 109

Taipan

Φ = 3.7 x 1010 n/cm2/s Φ(10-100 meV) = 2.9 x 1010

1

2

3

4

5C B A

1 % contoursvariation:

6% (h) x 4% (v)

1

2

3

4

5C B A

til

h i l1 % contoursvariation:

7% (h) x 2% (v)

Φt = 2.5 x 109 n/cm2/sΦ(10-100 meV) = 1.8 x 109

Page 22: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL: CNS flux distribution (pinhole measurement)

CG4Φ ~ 3.6 x 1010 n/cm2/s Φ(< 10 meV) = ? x 1010

10 % contours

1

2

3

4

5

6

7HGFEDCBA

Page 23: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL CNS: cold neutron spectrum (CG4)

Peak in cold neutron spectrum at reactor face: λ ~ 3 Åwith shoulder at: λ ~ 1.1 Å (rethermalization?)

5000

15000

25000

35000

45000

55000

65000

75000

85000

0.0 2.0 4.0 6.0 8.0 10.0

wavelength (A)

neut

ron

coun

ts

0

2500

5000

7500

10000

12500

TG4, 300 kW

CG4, 19 MW

Page 24: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Early diffraction patterns from Echidna

Neutron powder diffraction data for Al2O3 collected for ~5hHRPD: 2m=120˚, =1.49A; Echidna: 2m=90˚, =1.54A)

Page 25: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

First Diffraction Patterns on WOMBATHigh-Intensity Powder Diffractometer

24 February 2007

MgO

Alumina

Page 26: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

First Beam onKOWARI Strain ScannerJune 18th

Page 27: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

First SANS measurements – Natural Opal & Graphite

4 September 2008 and following days

Page 28: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Summary of neutron beam performance tests

~ 1.3 x 1010 [2]Cold neutron flux at RF face for CG3 (E < 10 meV)

~ 2.3 x 1010 [1]Thermal neutron flux at RF for TG3 (E < 100 meV)

6.4 x 109Cold neutron flux in NGH for CG3 (E < 10 meV)

2.5 x 1010Cold neutron flux at RF for CG4 (E < 10 meV)

2.8 x 109Thermal neutron flux in NGH for TG3 (E < 100 meV)

4.0 x 1010Thermal neutron flux at RF for TG4 (E < 100 meV)

OPAL measured flux(20 MW equiv)( in n/cm2/sec)

Performance Acceptance Criteria(RF = reactor face)(NGH = neutron guide hall)

[1] estimated with TG4 spectrum calibration factor[2] estimated with CG4 spectrum calibration factor

Page 29: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Radioisotopes for Nuclear Medicine/ Industrial Isotopes

• Total of 17 Bulk Irradiation Facilities arranged in three different classes, principally for the production of Molybdenum-99 and Iodine-131

• Total of 55 Long Residence Time Facilities available for the production of a range of isotopes for medical, industrial and research purposes.

Page 30: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Low Flux FacilitiesMo-99

Medium Flux FacilitiesI-131

High Flux Facilities

Bulk irradiation facilities

Page 31: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Results - BIFLF04

0

2E+13

4E+13

6E+13

8E+13

1E+14

1.2E+14

-200 0 200 400 600 800

Position from top [mm]

Ther

mal

flux

measuredMCNP

LF05

0

2E+13

4E+13

6E+13

8E+13

1E+14

1.2E+14

-200 0 200 400 600 800

Position from top [cm]

Ther

mal

flux

measuredMCNP

Compare calculations and measurements

Page 32: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Manufacture of radiopharmaceuticals

Page 33: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

The Production Process

LEU in reactor for irradiation &

Mo-99 from fission process

Mo-99 separated Tc-99m Generatorto

Customer

Page 34: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

LEU Mo99 Production in OPAL• Al clad UAl dispersion flat plate target

• 19.75% enriched U• Irradiated at 9x1013 n/cm2/s for 3-7 days• Plates dissolved in sodium hydroxide• Uranium precipitates and captured in filter• Dry filter cakes stored in non-critical array• Separation by ion exchange & successive

purification steps• Radioiodines remain in solution• I-131 recovered for use as a product• Hydrogen released during dissolution is

immediately converted to water via CuO2 wires

Page 35: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

6 facilities for silicon irradiation at OPAL suitable for 5”, 6”and 8” diameter silicon crystals

Facilities are located in the reactor D2O reflector vessel exposed to a neutron flux with Cd ratio > 1000 (approx)

Silicon irradiation

Silicon crystals are irradiated in aluminum cans in rotating rigs and water cooled

Customer base – Japan & Europe electronics suppliers

World market share - ~ 10%

Page 36: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Results – Si NTD

---+/- 5%---> 2002.91E+12

3.5E12 (+/- 20%)NTD-6

+/- 5% +/- 5%---> 2001.44E+13

1.9E13(+/- 30%)NTD-3

---+/- 5%2764> 2002.69E+12

3.2E12 (+/- 20%)NTD-2

+/- 2% +/- 5%---> 2008.32E+12

1.0E13 (+/- 20%)NTD-1

Measured Value

RequirementMeasured Value

RequirementMeasured Value

Requirement

Uniformity (Wafer analysis)

Thermal to Fast ratioThermal Neutron Flux [n/cm2s]

Page 37: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Neutron activation - NAA and DNAA

Page 38: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

DNAA terminal station• short residence time• 6.3 x 1012 cm-2 s-1

Page 39: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

DNAA can loading device

Page 40: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

NAA terminal station• short residence time• 2.7 x 1013 cm-2 s-1

Page 41: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

NAA sample loading

Page 42: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Commissioning Stages• Pre- Commissioning: systems check

• Stage A – Cold commissioning: integration

• Stage B1 – load fuel & first criticality• Stage B2 – low power tests• Stage C – Power ascension and full power tests

• Performance demonstration tests

Page 43: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

12th August 2006

Page 44: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 45: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL opened 20 April 2007

Page 46: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Repairs to OPAL reflector vessel

1. Stop the leak of H2O from reactor pool into reflector vessel (contaminating D2O)

2. Purify the D2O (~99.7%)

Helium gas leak test

gas bubbles

planned duration of each process is ~ 1 month

Page 47: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 48: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Timeline of Events To Date

Dec 2009Clamps applied

Jan 2007Reduction in D2O

purity observed

Feb 2007Leak test

confirms leaks

Mar 2007Pressure

Increase #1

Apr 2007Pressure

Increase #2

Sep/Oct 2007Micro-particle

injection

May 2007Repair optionsdesign review

Feb 2008HW isotopicpurif. design

review

June/July 2008Reactor S/DLeak tests

Nov 2008HW

replacement

2011HW isotopic

purification system

Page 49: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Research reactor operation

• Reactor Availability & Reliability

In FY 09/10Availability 73% – target was 70%To plan 93% – target was 90%

Page 50: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Research reactor operation

• Utilisation Neutron beams – CNS out of service for ~6 months in FY –

problems for major customer Irradiations U-plates for Mo99 – regular 2 runs/week ramping up

to 4 runs per week Other radiopharmaceuticals DNAA & NAA irradiations Neutron Doped Silicon – $2M in revenue in 09/10 year

Page 51: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Planning

• ANSTO Strategic & Business Plans

• OPAL Long Term Plan• Business Plan – integrated into

budget process Tiered process Board endorsement

Page 52: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

HEATHCOTE ROAD

N

Attachment A: Site Master Plan

ADMIN / PROF SERVICES

HOSTEL

8

STORES

RECREATION

ADJUNCT UNIVERSITY CAMPUS

MAJOR RECREATION / TOURISMDEVELOPMENT ON TIP SITE

COMMERCIAL

WASTE

ROADS / INFRASTRUCTURE / LANDSCAPE

NEW ILLAWARRA ROAD

LABS / OFFICE / W’SHOPS

VISITOR CENT/ LECTURE THEATRE

OPAL / BRAGG

Page 53: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Cooling Tower

SCS Pumps& Pipework

CERS Chillers

Auxiliary Bldg

DieselGenerators

Page 54: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

PRINCIPLES

• Multi-purpose• Safety• Flexibility• Sustainability• International • Responsive

Page 55: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

KEY CRITERIA

• Asset ManagementPlant maintenanceCondition monitoringSpares and logisiticsComponent replacementObsolescencePlans and IT system linkages

Page 56: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 57: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Irradiated detectorDisassembly operation

Disassembled detectorshowing degraded cables

Detector withcables connected

Detector assembly(inside watertight container)

Page 58: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

KEY CRITERIA

• Research ExcellenceCold Neutron SourceGuide opticsBeam instrumentsUser accessOther research facilities – NAA,

Reactor neutronics and thermal-hydraulics

Page 59: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

OPAL / Neutron Guide Hall

Page 60: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

From OPAL Preliminary Safety Analysis Report (May 2001)

Page 61: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

KEY CRITERIA

• People PlanningLevel of redundancy (key staff)Training & re-trainingSuccession PlanningLevel of knowledge & type of

knowledge

Page 62: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 63: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 64: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

KEY CRITERIA

• Regulatory Interface Systems to assure complianceManaging relationshipsSafety Case up to dateUnderstanding Regulatory

Expectations

Page 65: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 66: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

ACHIEVMENTS

• Defects being reduced• Heavy Water Purity stabilising• Finished Commissioning• International Recognition• New Building approved• Increased Production• Improved Reliability• Increased Staff

Page 67: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 68: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Science – what are the big opportunities with OPAL? Industrial Problems

Oil and gas exploration/extractionNuclear: Gen-IV reactors, Fusion materialsHydrogen Economy, fuel cells, etc.FoodIn-situ processes in manufacturing, etc. (e.g. welding, grinding, chemical reactions, extrusion, deformation, …)

Biology in the post-genomic eraInteractions between biomoleculesStructure & function of membrane proteinsBio-devices

Page 69: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Future directions • OPAL is a world-class research reactorPerformance in top 5% of more than 250 research

reactors world-wide• OPAL provides neutrons for:World class neutron scattering instruments used to

study structure of materials for scientific research and industrial applications

Production of high quality radiopharmaceuticals for nuclear medicine

Irradiation of silicon to produce high quality semiconductors

• OPAL supports Australia's health, environmental, industrial and national security objectives

Page 70: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine
Page 71: Australia’s new research reactor: commissioning, operation, …rmb.ipen.br/DOC_RMB/DOC_REFERENCIA/OUTROS/Visita ao OPAL... · 2010-12-13 · Radioisotopes for Nuclear Medicine

Thank you